In Brief
Ogasawara et al. find that dopamine neurons in the substantia nigra are activated when animals are required to inhibit inappropriate actions. Disruption of nigrostriatal dopamine signaling impaired this inhibition behavior, as seen in neurological/psychiatric disorders with dopaminergic dysfunctions.
INTRODUCTION
Animals need to inhibit inappropriate actions that would lead to unwanted outcomes. This ability, called response inhibition or inhibitory control, is an essential factor of executive function, and its neural substrate has been explored in humans and experimental animals using the stop-signal task (Logan and Cowan, 1984) . In this task, subjects are required to cancel a planned or ongoing motor action when they occasionally encounter a cue referred to as a ''stop signal.'' Previous studies have demonstrated that neural circuitry involving the frontal cortex and the basal ganglia participates in the brain mechanism that regulates response inhibition. In particular, a series of electrophysiological studies in monkeys by Schall and colleagues has shown that specific regions of the lateral prefrontal and medial frontal cortex play crucial but different roles in saccadic response inhibition (Hanes et al., 1998; Ito et al., 2003; Stuphorn et al., 2000 Stuphorn et al., , 2010 Stuphorn and Schall, 2006 ; see also Xu et al., 2017) . Although whether the basal ganglia contribute to response inhibition remains to be determined in monkeys, it has electrophysiologically been shown in rodents that neurons in some nuclei of the basal ganglia transmit signals associated with canceling motor actions (Mallet et al., 2016; Schmidt et al., 2013) . Several studies in humans also suggest involvement of the cortico-basal ganglia circuitry in response inhibition (Aron et al., 2003; Aron and Poldrack, 2006; Chen et al., 2009; Duann et al., 2009; Li et al., 2006) . Especially the major neural pathways (i.e., the indirect and hyperdirect pathways) constituting the cortico-basal ganglia circuitry have recently attracted much attention as essential substrates for response inhibition (Jahfari et al., 2011; Li et al., 2008; Schmidt et al., 2013; Zandbelt and Vink, 2010) . Whereas the direct pathway is thought to promote motor behavior, the indirect and hyperdirect pathways are considered to serve as a brake to stop it through their inhibitory actions on cortico-basal ganglia signaling (DeLong, 1990; Nambu et al., 2002) .
Clinical observations also suggest a possible neural basis for response inhibition. Impairments in response inhibition often accompany neurological/psychiatric disorders with dysfunctions of the dopamine system; for example, Parkinson's disease (Gauggel et al., 2004; Obeso et al., 2011) . Although Parkinson's disease is characterized by motor symptoms, patients with this disease develop deficits across many aspects of executive function, including working memory, attention, and response inhibition (Nieoullon, 2002) . In those patients, deep brain stimulation of the subthalamic nucleus, a component of the basal ganglia, improves not only motor functions (Obeso et al., 2001) but also the performance of response inhibition (van den Wildenberg et al., 2006) and enhances the electroencephalographic frontal activity related to response inhibition (Swann et al., 2011) . These studies suggest a contribution of the dopamine system to the fronto-basal ganglia link that mediates response inhibition. Because dopamine released in the striatum, where the indirect pathway originates, is an important modulator of this pathway (Gerfen and Surmeier, 2011; Kreitzer and Malenka, 2008) , dopamine's contribution is consistent with the idea that the indirect pathway is involved in response inhibition (Jahfari et al., 2011; Li et al., 2008) . However, although dopamine neurons are well known for their strong responses to rewards and for their crucial roles in motivation and reinforcement (Cohen et al., 2012; Kawagoe et al., 2004; Montague et al., 1996; Morris et al., 2004; Satoh et al., 2003; Schultz, 1998; Wise, 2004) , how dopamine regulates response inhibition remains unclear.
To address this issue, here we examined the roles of dopamine signals transmitted to the striatum in response inhibition. Using a saccadic version of the stop-signal task in macaque monkeys, we found that topographically distributed dopamine neurons in the substantia nigra and striatal neurons located in the caudate nucleus were activated when the monkey was required to cancel a planned saccadic eye movement. Pharmacological blockade of dopaminergic neurotransmission in the caudate nucleus impaired the performance of canceling saccadic eye movements. Our findings suggest a causal contribution of nigrostriatal dopamine signaling to response inhibition.
RESULTS

Saccadic Countermanding Task and Behavioral Performance
We trained two monkeys (monkeys M and E) to perform a saccadic countermanding task ( Figure 1A ) that has been used in human patients and nonhuman primates to evaluate the capability of response inhibition and elaborate its neural substrate (Hanes and Carpenter, 1999; Hanes and Schall, 1995; Thakkar et al., 2011) . Each trial started with the presentation of a fixation point. While the monkey was fixating the point, the point disappeared, and a saccadic target was simultaneously presented on the right or left side of the point. In 70% of the trials (nostop signal trials), the monkey was required to make a saccadic eye movement to the target. In the remaining 30% (stop signal trials), the fixation point reappeared as a stop signal with a delay after the onset of the saccadic target. The monkey was required to cancel a planned saccadic eye movement. The delay between (C) Schematic diagram of the race model. If the GO process reaches its threshold before the STOP process, then a saccadic eye movement is generated (top; non-canceled trials). The duration of the GO process is the reaction time of the eye movement (saccadic reaction time [RT] ). If the STOP process reaches its threshold before the GO process, then the saccadic eye movement is canceled (center; canceled trials). The duration of the STOP process is the stop-signal reaction time (SSRT). The SSRT is estimated from the distribution of the durations of the GO process (i.e., the RTs of saccadic eye movements in no-stop signal trials) (bottom). (D) Distributions of the SSRTs in each recording session for each monkey. See also Figure S1 . saccadic target onset and stop signal onset is referred to as ''stop-signal delay'' and ranged from 184 to 334 ms in 50-ms step for monkey M and from 84 to 234 ms in 50-ms step for monkey E.
In stop signal trials, the monkeys successfully canceled a saccadic eye movement to the target when the stop-signal delay was short. As the stop-signal delay became longer, the monkeys increasingly failed to cancel the eye movement ( Figure 1B ; see also Figure S1A for the variation of performance across sessions). The probability of trials in which the monkey failed to cancel a saccadic eye movement (non-canceled trials) as a function of the stop-signal delay was significantly fit by a logistic function (monkey M, R 2 = 0.78, p < 1.0 3 10 À5 , n = 141 sessions; monkey E, R 2 = 0.77, p < 1.0 3 10 À5 , n = 100 sessions; F test). The behavioral data indicated that canceling saccadic eye movements became more demanding as the stop-signal delay increased.
A critical behavioral index in quantifying the performance of canceling planned saccadic eye movements is the duration that is required to cancel the eye movements. This duration, termed stop-signal reaction time (SSRT), cannot directly be measured as raw data but can be estimated by a mathematical model that assumes a race between the GO and the STOP processes (Figure 1C; Logan and Cowan, 1984) . The GO process is invoked by presentation of the saccadic target, and a saccadic eye movement is generated when the GO process finishes. The STOP process is invoked by presentation of the stop signal, and the eye movement is canceled when the STOP process finishes before the GO process. The SSRT is the duration that the STOP process needs to finish and can be estimated from the distribution of the durations of the GO process (i.e., the reaction times of saccadic eye movements in no-stop signal trials) (see STAR Methods for the estimation method; see Figure S1B for saccadic reaction times in no-stop signal trials). We estimated the SSRTs based on the behavioral data obtained from single-unit recording in each session (mean ± SD = 89.8 ± 18.3 ms in monkey M and 112.6 ± 16.9 ms in monkey E) (Figures 1D and S1C).
Response of Dopamine Neurons to the Stop Signal
While the monkeys were performing the countermanding task, we first recorded single-unit activity from 76 dopamine neurons (40 in monkey M and 36 in monkey E) in the ventral midbrain, including the substantia nigra pars compacta (SNc) and the ventral tegmental area (VTA). Recent electrophysiological studies have found that dopamine neurons not only respond to rewarding events but also represent signals related to novel, salient, and even aversive experiences (Brischoux et al., 2009; Bromberg-Martin et al., 2010; Horvitz, 2000; Joshua et al., 2008; Matsumoto, 2015; Matsumoto et al., 2016; Redgrave and Gurney, 2006) . Here we examined how dopamine neurons responded to the stop signal that invoked the process for canceling saccadic eye movements. We identified putative dopamine neurons based on well-known electrophysiological criteria: a low background firing rate at around 5 spikes/s, a broad spike waveform in clear contrast to neighboring neurons with a high background firing rate in the substantia nigra pars reticulata ( Figure S2 ), and a phasic increase in discharge caused by an unexpectedly delivered reward.
An example dopamine neuron was activated when the stop signal was presented ( Figure 2A ). This activation was stronger in trials in which the monkey successfully canceled a saccadic eye movement (canceled trials) compared with those in which the animal failed to cancel it (non-canceled trials). The activation occurred irrespective of the direction of planned saccadic eye movements that were canceled by the stop signal (i.e., ipsilateral or contralateral to the recording hemisphere). To clarify whether dopamine neurons are involved in canceling planned saccadic eye movements, we compared their activity in trials in which saccadic eye movements were canceled (canceled trials) versus those in which the eye movements were properly executed (latency-matched no-stop signal trials) (see STAR Methods for details). Figure 2B shows the receiver operating characteristic (ROC) value of all recorded dopamine neurons that was determined by comparing their activities in the two trial types. A subset of the dopamine neurons exhibited a phasic activation aligned at stop signal onset in canceled trials, and the same pattern of activation was observed under both the ipsilateral and contralateral conditions.
Of the 76 dopamine neurons, 28 neurons showed a significant increase in their activity in canceled trials compared with latency-matched no-stop signal trials in at least one of the ipsilateral and contralateral conditions (ipsilateral condition, 22 neurons; contralateral condition, 16 neurons; both conditions, 10 neurons; p < 0.05, Wilcoxon rank-sum test). The proportion of the neurons with a significant increase was not significantly different in the ipsilateral versus contralateral conditions (p = 0.32, chi-square test). Figure 3A shows the averaged activity of these 28 neurons in a combination of the ipsilateral and contralateral conditions (see STAR Methods for details of population analyses; see Figure S3 for data for individual monkeys). Given that the excitatory dopamine signal regulates the performance of canceling saccadic eye movements, the dopamine neuron activation evoked by the stop signal is expected to start earlier than the SSRT; i.e., the duration the brain needs for canceling saccadic eye movements. Figure 3B shows dopamine neuron activity aligned at the SSRT. We found that the onset of the dopamine neuron activation preceded the SSRT by at least 12 ms as a population, although only a few neurons exhibited an activation that preceded the SSRT at the singleneuron level (see Figure S4A for the onset of each dopamine neuron).
We next found that the dopamine neuron activation evoked by the stop signal was enhanced as the stop-signal delay increased ( Figure 3C ), which was proven by a significantly positive correlation coefficient between the dopamine neuron activation and the stop-signal delay (r, mean ± SD = 0.16 ± 0.19, p = 3.2 3 10 À4 , n = 28, Wilcoxon signed-rank test) ( Figure 3D ). Furthermore, we found that the dopamine neuron activation evoked by the stop signal was modulated depending on whether canceling a saccadic eye movement was successful or failed ( Figure 3E ). Although the dopamine neuron activation was modulated by the stop-signal delay as well ( Figure 3D ), here we removed this effect by analyzing neuronal activity only in trials with a certain stop-signal delay (the third shortest stop-signal delay; 284 and 184 ms in monkeys M and E, respectively). In this stop-signal delay, canceling saccadic eye movements was equally successful and failed ( Figure 1B) , and we were able to collect enough data to compare neuronal activities in canceled versus non-canceled trials. On average, the activation evoked by the stop signal was significantly stronger in canceled trials than in non-canceled trials (canceled trials, mean ± SD = 12.7 ± 7.4 spikes/s; non-canceled trials, mean ± SD = 7.6 ± 6.4 spikes/s; p = 2.1 3 10 À4 , n = 28, Wilcoxon signed-rank test). Even at the individual neuron level, 6 of the 28 neurons exhibited a significantly stronger activation in canceled trials than in non-canceled trials in spite of the limited number of these trials (p < 0.05, Wilcoxon rank- conditions. The modulation of each neuron is presented as a row of pixels. The color of each pixel represents the receiver operating characteristic (ROC) value that was determined by comparing the discharge rate in canceled versus latency-matched no-stop signal trials. The ROC value was calculated using a 50-ms test window sliding with a 10-ms step. Warmer colors (ROC > 0.5) indicate higher discharge rates in canceled trials, whereas cooler colors (ROC < 0.5) indicate higher discharge rates in latency-matched no-stop signal trials. Open circles indicate the SSRT of each recording session. (C) Neuronal modulation between canceled and non-canceled trials of the 28 neurons with a significant increase in their activity in canceled trials compared with latency-matched no-stop signal trials under at least one of the ipsilateral and contralateral conditions (p < 0.05, Wilcoxon ranksum test). Warmer colors (ROC > 0.5) indicate higher discharge rates in canceled trials, whereas cooler colors (ROC < 0.5) indicate higher discharge rates in non-canceled trials. See also Figure S2 . sum test) (see Figure 2C for the modulation of each neuron). These results indicated that the magnitude of the dopamine neuron activation evoked by the stop signal was correlated with the performance of canceling planned saccadic eye movements.
As revealed by the difference in neuronal activity between canceled and non-canceled trials, the dopamine neuron activation evoked by the stop signal was correlated with the performance of canceling saccadic eye movements. Even in noncanceled trials, however, dopamine neurons were weakly but significantly activated by the stop signal compared with latency-matched no-stop signal trials (non-canceled trials, mean ± SD = 7.6 ± 6.4 spikes/s; latency-matched no-stop signal trials, mean ± SD = 4.8 ± 3.7 spikes/s; p = 0.017, n = 28, Wilcoxon signed-rank test) ( Figure S4D ). Thus, dopamine neurons were activated by the stop signal even when the monkey failed to cancel a saccadic eye movement, suggesting that the activation did not simply reflect the performance itself. To further test how the dopamine neuron activation related to the performance of canceling saccadic eye movements, we next examined the correlation between the magnitude of the activation and the probability of non-canceled trials (i.e., the probability of failed trials) that varied across recording sessions even for a given stopsignal delay (see Figure S1A for the variation of performance across recording sessions). We observed a significant correlation between them (r = 0.33, p = 7.4 3 10 À4 , n = 100) ( Figure S4G ), suggesting that dopamine neurons were more strongly activated by the stop signal during recording sessions in which the monkey more often failed to cancel a saccadic eye movement.
Previous studies have demonstrated that dopamine neurons represent distinct signals in monkeys in a topographic fashion that is dependent on their locations in the SNc and VTA (Matsumoto and Hikosaka, 2009; Matsumoto and Takada, 2013) . According to these studies, dopamine neurons in the ventromedial part of the SNc and VTA represent a value-related signal called reward prediction error, whereas those in the dorsolateral part of the SNc represent a signal related to the salience of external events. In the present study, we also found that the dopamine neurons activated by the stop signal were not uniformly scattered over the SNc and VTA. These neurons were observed mainly in the dorsolateral part of the SNc ( Figure 4A ). This spatial localization was statistically verified by a significant negative correlation between the neuronal response to the stop signal and the depth of the recording site (r = À0.45, p = 3.8 3 10 À5 , n = 76) ( Figure 4B ). Moreover, we split all recorded dopamine neurons into two groups according to their recording depth. Figure 4C indicates the averaged activities of the shallower and deeper groups. On average, the activation evoked by the stop signal was significantly stronger in the shallower group than in the deeper group (shallower, mean ± SD = 7.4 ± 4.8 spikes/s, n = 38; deeper, mean ± SD = 4.6 ± 3.7 spikes/s, n = 38; p = 6.9 3 10 À4 , Wilcoxon rank-sum test) ( Figure 4D ). These results suggest that only a topographically distributed group of dopamine neurons participates in the neural process that cancels planned saccadic eye movements.
Response of Caudate Neurons to the Stop Signal
We so far found that dopamine neurons in the dorsolateral part of the SNc were predominantly activated by the stop signal that invoked the process for canceling planned saccadic eye movements and that their activity was correlated with the performance of canceling the eye movements. To understand (B) Averaged activity of the 28 dopamine neurons aligned at the SSRT. SDFs are shown for canceled trials (red curve) and latency-matched no-stop signal trials (black curve). The vertical dotted line represents the time when the difference in the averaged discharge rate between canceled and latency-matched no-stop signal trials becomes larger than 2 SD of the difference during the 250-ms time window before target onset. (C) Effect of the stop-signal delay on the averaged activity of the 28 dopamine neurons. Their averaged neuronal modulation evoked by the stop signal (i.e., the difference in their averaged activity between canceled and latency-matched no-stop signal trials) is aligned at stop signal onset and shown for the shortest SSD (SSD1, light red), the second shortest SSD (SSD2, red), and the third shortest SSD (SSD3, dark red). Data obtained with the longest SSD (SSD4) were precluded from the analysis because the monkey failed to cancel an eye movement in most of the trials, and, consequently, we were unable to collect enough data for a statistically valid analysis. (D) Distribution of the correlation coefficients of the 28 dopamine neurons between SSD and the magnitude of neuronal modulation evoked by the stop signal. the role of this excitatory dopamine signal in the basal ganglia circuitry, we next investigated what signals are represented in the caudate nucleus, which receives the dopaminergic input from the dorsolateral part of the SNc (Haber et al., 2000) . We recorded single-unit activity from 165 neurons in the caudate nucleus (101 in monkey M and 64 in monkey E; see Figure S5 for histology). The recording sites overlapped the region receiving projections from the frontal eye field and the supplementary eye field, which have been shown to participate in saccadic response inhibition (Parthasarathy et al., 1992) .
As seen in dopamine neurons, we observed that a number of neurons in the caudate nucleus were more strongly activated when the stop signal was presented and the monkey successfully canceled a planned saccadic eye movement (canceled trials) compared with latency-matched no-stop signal trials in which the stop signal was not presented and the animal properly executed the eye movement (see Figure 5A for an example neuron and Figure 5C for all recorded neurons). Unlike dopamine neurons, the activity of some other caudate neurons was rather suppressed in canceled trials in comparison with latencymatched no-stop signal trials (see Figure 5B for an example neuron). These responses of caudate neurons were often modulated by the direction of planned saccadic eye movements that were canceled by the stop signal.
Of the 165 caudate neurons, 59 neurons exhibited a significant increase in their activity in canceled trials compared with latency-matched no-stop signal trials in at least one of the ipsilateral and contralateral conditions (ipsilateral condition, 39 neurons; contralateral condition, 32 neurons; both conditions, 12 neurons; p < 0.05, Wilcoxon rank-sum test). Hereafter we classified these caudate neurons as the increase type. Conversely, 74 caudate neurons showed a significant decrease in their activity in canceled trials under at least one of the conditions (ipsilateral condition, 31 neurons; contralateral condition, 53 neurons; both conditions, 10 neurons; p < 0.05, Wilcoxon rank-sum test). These neurons were more strongly activated when the monkey executed a saccadic eye movement than when the animal canceled the eye movement. Hereafter we classified these caudate neurons as the decrease type. The proportion of the increase-type neurons was not significantly different under the ipsilateral versus contralateral conditions (p = 0.39, chi-square test), whereas that of the decrease-type neurons was significantly larger under the contralateral condition (p = 0.009, chi-square test). Thus, although caudate neurons were more preferentially activated when the monkey executed a saccadic eye movement toward the contralateral than the ipsilateral direction (decrease type), consistent with previous findings (Hikosaka et al., 1989; Takikawa et al., 2002) , they were activated when the monkey canceled the eye movement regardless of the direction (increase type). Figure 6A shows the averaged activities of the increase-type (top) and decrease-type (bottom) neurons in a combination of the ipsilateral and contralateral conditions (see STAR Methods for details of population analyses; see Figure S3 for data for individual monkeys). The modulation of the increase-type neurons evoked by the stop signal started earlier than the SSRT by at least 7 ms as a population ( Figure 6B, top) , although only a few neurons exhibited a modulation that started earlier than the SSRT at the single-neuron level (see Figure S4B for the modulation onset of each increase-type neuron). The modulation of the decrease-type neurons started later than the SSRT even as a population ( Figure 6B , bottom; see Figure S4C for the modulation onset of each decrease-type neuron). The modulation of the increase-type neurons was enhanced as the stop-signal delay increased (correlation coefficient between the modulation and the stop-signal delay, mean ± SD = 0.12 ± 0.22, p = 1.2 3 10 À4 , n = 59, Wilcoxon signed-rank test) ( Figures 6C and 6D , top), whereas the modulation of the decrease-type neurons was not affected by the stop-signal delay (correlation coefficient between the modulation and the stop-signal delay, mean ± SD = 0.025 ± 0.27, p = 0.38, n = 74, Wilcoxon signed-rank test) (Figures 6C and 6D, bottom) . Notably, the increase-type neurons exhibited a significantly stronger activation in canceled trials than in non-canceled trials (canceled trials, mean ± SD = 8.7 ± 5.9 spikes/s; non-canceled trials, mean ± SD = 6.1 ± 7.3 spikes/s; p = 7.5 3 10 À3 , n = 59, Wilcoxon signed-rank test) ( Figure 6E , top; see Figure 5D , top, for the modulation of each increase-type neuron), whereas the decrease-type neurons displayed a significantly stronger activation in noncanceled trials than in canceled trials (canceled trials, mean ± SD = 4.5 ± 5.7 spikes/s; non-canceled trials, mean ± SD = 6.3 ± 7.4 spikes/s; p = 6.8 3 10 À3 , n = 74, Wilcoxon signedrank test) ( Figure 6E , bottom; see Figure 5D , bottom, for the modulation of each decrease-type neuron). This indicates that the activities of both neuron types were correlated with the performance of canceling planned saccadic eye movements.
As seen in dopamine neurons, the increase-type neurons exhibited a weak but significant increase in their activity even in non-canceled trials compared with latency-matched no-stop signal trials (non-canceled trials, mean ± SD = 6.1 ± 7.3 spikes/s; latency-matched no-stop signal trials, mean ± SD = 3.8 ± 5.1 spikes/s; p = 1.1 3 10 À3 , n = 59, Wilcoxon signed-rank test) ( Figure S4E ). Thus, the increase-type neurons were activated by the stop signal even when the monkey failed to cancel a saccadic eye movement. On the other hand, the activity of the decrease-type neurons did not significantly change in non-canceled trials versus latency-matched no-stop signal trials (non-canceled trials, mean ± SD = 6.3 ± 7.4 spikes/s; latency-matched no-stop signal trials, mean ± SD = 7.5 ± 7.4 spikes/s; p = 0.051, n = 74, Wilcoxon signedrank test) ( Figure S4F ). These results suggest that the activity of the decrease-type neurons reflected whether the monkey would execute or cancel a saccadic eye movement, whereas the activity of the increase-type neurons did not simply represent the performance itself. Furthermore, we found that the magnitude of the modulation of the increase-type neurons evoked by the stop signal was significantly correlated with the probability of non-canceled trials that varied across recording sessions (r = 0.20, p = 0.0089, n = 176) ( Figure S4H ), suggesting that these neurons were more strongly activated by the stop signal during recording sessions in which the monkey more often failed to cancel a saccadic eye movement. The modulation magnitude of the decreased-type neurons, on the other hand, was not significantly correlated with the probability of non-canceled trials (r = À0.043, p = 0.55, n = 198) ( Figure S4I ). Taken together, in particular, the increase-type neurons in the caudate nucleus shared similar electrophysiological properties with dopamine neurons.
Pharmacological Blockade of Dopaminergic Neurotransmission in the Caudate Nucleus
We found that dopamine neurons, mainly in the dorsolateral part of the SNc, were activated by the stop signal. A subset of caudate neurons, which would receive the dopamine signal, also exhibited an activation evoked by the stop signal, especially when the monkey successfully canceled a planned saccadic eye movement. To test whether dopaminergic neurotransmission in the caudate nucleus has a causal role in canceling saccadic eye movements, we next injected a dopamine antagonist SCH23390 (4 injections in monkey M and 8 injections in monkey E) or haloperidol (6 injections in monkey M and 8 injections in monkey E), which mainly prevents D1 or D2 receptor signaling, respectively, into the caudate nucleus of one hemisphere in the two monkeys (see Figure S5 for the injection sites).
In an experiment in which the D2 antagonist was injected into a representative site, the monkey often failed to cancel a saccadic eye movement after the injection compared with the pre-injection control (Figure 7A , top; see also Figure S6A , top, for data for all injection experiments). In general, the caudate nucleus is thought to regulate saccadic eye movements contralateral to a given hemisphere. Notably, however, the effect of the D2 antagonist was observed when the monkey was required to cancel a saccadic eye movement ipsilateral, but not contralateral, to the injection hemisphere. The injection of the D1 antagonist into another representative site also impaired the performance of canceling saccadic eye movements only in the ipsilateral condition ( Figure 7A , bottom; see also Figure S6A , bottom, for data for all injection experiments). To statistically analyze the effects of the D1 and D2 antagonists on the performance of canceling saccadic eye movements, we compared the stop-signal delay at which the monkey failed in 50% of trials under pre-versus post-injection conditions (DZ; Figure 7A ). In the representative experiments, the impaired performance under the ipsilateral condition resulted in a significant decrease in the stopsignal delay incurring 50% failed trials (i.e., non-canceled trials) (D1 antagonist, DZ = À56.7 ms, p < 0.002; D2 antagonist, DZ = À59.2 ms, p = 0.002; bootstrap test with 1,000 repetitions).
On average, both the D1 and the D2 antagonist injections significantly decreased the stop-signal delay under the ipsilateral condition (D1 antagonist, DZ, mean ± SD = À68.1 ± 57.1 ms, p = 2.4 3 10 À3 , n = 12; D2 antagonist, DZ, mean ± SD = À59.6 ± 34.4 ms, p = 1.2 3 10 À4 , n = 14; Wilcoxon signedrank test) but had no significant effect under the contralateral condition (D1 antagonist, DZ, mean ± SD = 14.5 ± 54.8 ms, p = 0.68, n = 12; D2 antagonist, DZ, mean ± SD = 5.9 ± 20.9 ms, p = 0.46, n = 14; Wilcoxon signed-rank test) ( Figure 7B,  top) . When the same amount of saline was injected into similar loci of the caudate nucleus as a control, the stop-signal delay incurring 50% failed trials remained unchanged ( Figures S6C  and S6D ). These results indicated that disruption of dopamine D1 and D2 signals in the caudate nucleus impaired the performance of canceling saccadic eye movements.
The performance of response inhibition largely depends on the SSRT; i.e., the duration the brain needs for canceling motor actions. We next analyzed the effects of the D1 and D2 antagonists on the SSRT. We estimated the SSRT based on the race model ( Figure 1C ) and compared the SSRT under pre-versus post-injection conditions for each injection experiment. On average, the D2 antagonist injection significantly increased the SSRT under the ipsilateral condition (DSSRT, mean ± SD = 20.5 ± 18.2 ms, p = 2.3 3 10 À3 , n = 14; Wilcoxon signed-rank test) but had no significant effect under the contralateral condition (DSSRT, mean ± SD = À7.6 ± 15.8 ms, p = 0.12, n = 14; Wilcoxon signed-rank test) ( Figure 7B, center) . On the other hand, the D1 antagonist injection exerted no significant effect under either the ipsilateral (DSSRT, mean ± SD = 6.4 ± 23.1 ms, p = 0.34, n = 12; Wilcoxon signed-rank test) or the contralateral condition (DSSRT, mean ± SD = À2.5 ± 21.6 ms, p = 0.85, n = 12; Wilcoxon signed-rank test).
The unilateral increase in the SSRT after the D2 antagonist injection is well consistent with the ipsilateral deficit in the performance of canceling saccadic eye movements. It remains unclear, however, how the D1 antagonist injection impaired the performance without affecting the SSRT. Previous studies have reported that the performance of response inhibition also depends on the reaction time of motor actions (Emeric et al., 2007; Stuphorn and Schall, 2006) . The more quickly animals attempt to execute a motor action, the more difficult canceling the action becomes. We then analyzed the effects of the D1 and D2 antagonists on the reaction time of saccadic eye movements. On average, both antagonists significantly decreased the reaction time under the ipsilateral condition (D1 antagonist, DRT, mean ± SD = À45.8 ± 36.6 ms, p = 1.5 3 10 À3 , n = 12; D2 antagonist, DRT, mean ± SD = À36.6 ± 26.1 ms, p = 1.2 3 10 À4 , n = 14; Wilcoxon signed-rank test) but exerted no significant effect in the contralateral condition (D1 antagonist, DRT, mean ± SD = 10.7 ± 34.2 ms, p = 0.30, n = 12; D2 antagonist, DRT, mean ± SD = 2.5 ± 15.2 ms, p = 0.63, n = 14; Wilcoxon signed-rank test) ( Figure 7B , bottom; see Figure S7 for the distributions of saccadic reaction times under pre-and post-injection conditions). Thus, while the D2 antagonist seemed to impair the performance of canceling planned saccadic eye movements by altering both the SSRT and the saccadic reaction time, the D1 antagonist was likely to impair the performance only by affecting the saccadic reaction time.
To test whether the effects of the D1 and D2 antagonists were contingent on the performance of canceling saccadic eye movements, we finally examined the effects of these antagonists on saccadic eye movements in a simple, visually-guided saccade task in which the stop signal was not presented ( Figure 7C ). As seen in the saccadic countermanding task, the D1 antagonist injection significantly decreased the saccadic reaction time under the ipsilateral condition (DRT, mean ± SD = À20.2 ± 13.2 ms, p = 0.031, n = 6; Wilcoxon signed-rank test). Notably, however, the D2 antagonist injection had no significant effect on the reac-tion time under the ipsilateral condition (DRT, mean ± SD = À2.8 ± 8.3 ms, p = 0.46, n = 8; Wilcoxon signed-rank test). Thus, the effect of the D2 antagonist on ipsilateral saccadic eye movements was observed only in the context in which the monkey was required to cancel the eye movement. Both antagonists, on the other hand, significantly increased the reaction time under the contralateral condition (D1 antagonist, DRT, mean ± SD = 46.8 ± 32.8 ms, p = 0.031, n = 6; D2 antagonist, DRT, mean ± SD = 15.8 ± 9.5 ms, p = 0.016, n = 8; Wilcoxon signed-rank test), which was not observed in the saccadic countermanding task.
DISCUSSION
In the present study, we revealed that a topographically distributed group of dopamine neurons in the SNc and striatal neurons in the caudate nucleus receiving the dopaminergic input were activated when the monkey was required to cancel a planned saccadic eye movement. These excitatory signals were correlated with the performance of canceling saccadic eye movements. By injecting D1 and D2 antagonists, we further elucidated a causal role of dopaminergic neurotransmission to the caudate nucleus in the performance of canceling the eye movements.
Notably, the dopamine neurons activated by the stop signal were distributed mainly in the dorsolateral part of the SNc. Although dopamine neurons are well known to encode a valuerelated signal called reward prediction error, recent studies in monkeys have shown that dopamine neurons in the dorsolateral part of the SNc transmit a signal related to the salience, rather than the value, of external events (Matsumoto and Hikosaka, 2009; Matsumoto and Takada, 2013) . Dopamine neurons in this region receive inputs from the superior colliculus (Redgrave and Gurney, 2006) , in which neurons also represent the salience of external stimuli (McPeek and Keller, 2002; Shen and Paré , 2014; White et al., 2017) and respond to the stop signal in the same saccadic countermanding task in monkeys (Paré and Hanes, 2003) . Because the distribution of dopamine neurons activated by the stop signal overlaps that of dopamine neurons signaling salience, the dopamine neuron activation evoked by the stop signal may reflect the salience of the stop signal that is critically salient to achieve the saccadic countermanding task. Consistent with this idea, dopamine neurons were more strongly activated by the stop signal as the stop-signal delay increased. The behavioral data indicated that canceling saccadic eye movements became more demanding as the stop-signal delay increased, and it can be considered that the stop signal turns more salient when it requires a more demanding action. In addition, the dopamine neurons activated by the stop signal tended to be activated by another salient stimulus in the countermanding task, i.e., the fixation point that signaled the start of trials ( Figures S4J and S4K) . By contrast, the dopamine neuron activation does not appear to reflect the value-related aspect of the stop signal. That is, although the monkey more often failed to cancel a saccadic eye movement (i.e., although the reward probability decreased) as the stopsignal delay increased, the dopamine neuron activation was enhanced by longer stop-signal delays. Taken together, our findings suggest that the nigrostriatal dopamine system may regulate saccadic response inhibition, probably by signaling the salience of the stop signal.
How does the dopamine neuron activation evoked by the stop signal, which we observed in our single-unit recordings, regulate the performance of canceling saccadic eye movements? Given that the dopamine neuron activation participates in the cancellation process, the activation is expected to start earlier than the SSRT. We found that, although the latency of the dopamine neuron activation preceded the SSRT at least by 12 ms as a population, only a few neurons exhibited a latency preceding the SSRT at the single-neuron level. The latency in the caudate nucleus, which receives the dopamine signal, preceded the SSRT only by 7 ms. Moreover, it should be noted here that the effect of released dopamine on postsynaptic activity is mediated by G-protein-coupled dopamine receptors, which are generally regarded as receptors that signal with slow speed (Beaulieu and Gainetdinov, 2011) . In addition, the conduction velocity of dopaminergic fibers is slower than that of non-dopaminergic fibers (e.g., 0.6 m/s for mesolimbic dopaminergic fibers and 2.4 m/s for mesolimbic non-dopaminergic fibers in rats) (Thierry et al., 1980) . Therefore, it does not become immediately clear whether or not the latency preceding the SSRT by 12 ms as a population is short enough for the dopamine neuron activation to regulate the performance of canceling saccadic eye movements.
A possible role of the dopamine neuron activation in canceling saccadic eye movements is ''proactive inhibition,'' which suppresses the eye movements in advance even before presentation of the stop signal. Human imaging studies have shown that the basal ganglia are involved in this process (Aron, 2011; Majid et al., 2013) . Although the role of the basal ganglia in proactive inhibition has not yet been elucidated at the single-neuron level, electrophysiological studies in monkeys have shown that neurons in the supplementary eye field (SEF) regulate the performance of saccadic response inhibition in a proactive manner. Neurons in the SEF respond to the stop signal in the saccadic countermanding task as well, but most of their responses start later than the SSRT (Stuphorn et al., 2010) . Nevertheless, electrical stimulation of the SEF improves the performance of canceling saccadic eye movements (Stuphorn and Schall, 2006) . Accordingly, the SEF has been thought to contribute to canceling saccadic eye movements by ''preparing'' the cancellation before presentation of the stop signal (Stuphorn et al., 2010) . Such a proactive inhibition process is guided by some information; for example, prior knowledge about the task and environment. Dopamine is an ideal neurotransmitter involved in this process. Dopamine released in the striatum is known to modulate the synaptic efficacy of the corticostriatal pathway that connects the SEF and caudate nucleus (Gerfen and Surmeier, 2011; Kreitzer and Malenka, 2008) . The synaptic effect seems to be instrumental in proactive inhibition, which requires long-lasting changes in a circuit state to keep the circuit ready to cancel motor actions. Thus, the dopamine neuron activation evoked by the stop signal would change the corticostriatal synaptic efficacy and, consequently, might inhibit subsequent saccadic eye movements by preparing for canceling the eye movements. Consistent with the idea that the nigrostriatal dopamine system regulates saccadic response inhibition in a proactive manner, we found that the magnitude of the dopamine neuron activation evoked by the stop signal was correlated with the reaction time of saccadic eye movement in the next no-stop signal trial (Figures S8D and S8E) . In other words, as dopamine neurons were more strongly activated by the stop signal, the eye movement in the next trial was more largerly delayed. Furthermore, as seen in the SEF (Stuphorn et al., 2010) , the activity of caudate neurons represented whether the monkey would successfully cancel or erroneously execute a saccadic eye movement even before presentation of the saccadic target ( Figures S8B and  S8C) . These results suggest that dopamine neurons and the caudate nucleus may proactively regulate saccade promotion by biasing the balance between the cancellation and execution of saccadic eye movement.
As discussed above, it is a critical issue whether and how the nigrostriatal system cooperates with the SEF to regulate the performance of saccadic response inhibition. The SEF and caudate nucleus constitute an oculomotor functional unit known as the cortico-basal ganglia oculomotor loop circuit (DeLong and Wichmann, 2015) . Consistent with the anatomical linkage, the neurophysiological properties of caudate neurons observed in the present study resemble those of SEF neurons. For instance, as observed in the SEF (Stuphorn et al., 2000) , a subset of caudate neurons was more strongly activated when the monkey canceled a saccadic eye movement (canceled trials) than when the animal executed the eye movement (no-stop signal trials), whereas another subset of caudate neurons was more strongly activated when the monkey executed a saccadic eye movement. In addition, neuronal modulations in both the SEF and the caudate nucleus were stronger when the monkey correctly canceled a saccadic eye movement than when it failed. Such a correlation with the performance, as well as the diversity of neuronal modulations and the proactive influence on the modulations, is a common feature across these structures. However, they do not share all of the electrophysiological features. Whereas the activation of caudate neurons evoked by the stop signal was modulated by the stop-signal delay, that of SEF neurons was not (Stuphorn et al., 2000) . These results suggest that the caudate nucleus does not simply receive signals from the SEF.
Although the role of the basal ganglia in response inhibition has not yet been elucidated in monkeys, human imaging studies have proposed that the indirect pathway of the basal ganglia plays a crucial role in response inhibition (Jahfari et al., 2011; Li et al., 2008; Zandbelt and Vink, 2010) . How do our findings in monkeys fit this proposal? In the present study, we injected D1 and D2 antagonists that prevent dopaminergic neurotransmission to the direct and indirect pathways, respectively, into the caudate nucleus. Although the D1 antagonist impaired the performance of canceling saccadic eye movements by decreasing the reaction time of the eye movements, the D2 antagonist impaired it not only by decreasing the reaction time but also by increasing the SSRT. Because the SSRT is the duration necessary for the brain to cancel saccadic eye movements (i.e., the duration necessary for the STOP process in the race model), the effect on this behavioral index implies that the dopamine signal to the indirect pathway participates in the neural process that cancels the eye movements (i.e., the STOP process). On the other hand, the saccadic reaction time is the duration necessary for the brain to generate saccadic eye movements (i.e., the duration necessary for the GO process in the race model). Thus, the effects of the D1 and D2 antagonists on saccadic reaction time indicate that dopaminergic neurotransmission is involved in the promotion of saccadic eye movements (i.e., the GO process) not only through the direct pathway but also through the indirect pathway. However, it is most likely that these pathways affect saccade promotion in different ways. In this respect, the present work has clearly demonstrated that the D1 antagonist decreased the reaction time regardless of the task context, whereas the D2 antagonist did so only in the context in which the monkey was required to cancel a saccadic eye movement. The context-dependent effect of the D2 antagonist is consistent with the idea that dopaminergic neurotransmission to the indirect pathway contributes to the proactive inhibition process that has been described above because the proactive inhibition process is executed only in the context in which animals are required to cancel motor actions. Our findings suggest that, although the dopaminergic input to the direct pathway simply affects the promotion of saccadic eye movements, the input to the indirect pathway serves as a brake to cancel the eye movements even before presentation of the stop signal.
Our electrophysiological and pharmacological findings lead to the idea that the dopamine neuron activation evoked by the stop signal regulates the performance of canceling saccadic eye movements through the indirect pathway of the basal ganglia. However, this idea does not perfectly fit the conventional theory of the indirect pathway. According to the conventional theory, excitatory dopamine signals suppress the activity of striatal neurons with D2 receptors in the indirect pathway that inhibits motor actions. Consequently, the excitatory dopamine signals ''disinhibit'' motor actions through the indirect pathway (Gerfen and Surmeier, 2011) . Contrary to this theory, our findings suggest that the excitatory dopamine signal evoked by the stop signal ''inhibits'' saccadic eye movements. A hint that may bridge the gap between the conventional theory and our findings is provided by our pharmacological observations that blockade of dopamine D2 signaling in the caudate nucleus impaired the performance of canceling saccadic eye movements ipsilateral, but not contralateral, to the injected hemisphere. In general, the direct and indirect pathways involving the caudate nucleus are thought to regulate contralateral saccadic eye movements. However, it has also been documented that the caudate nucleus influences ipsilateral saccadic eye movements as well but in an opposite manner. Electrical stimulation of the caudate nucleus in monkeys facilitates contralateral saccadic eye movements whereas it suppresses ipsilateral ones (Nakamura and Hikosaka, 2006) . This suggests that the caudate nucleus regulates contralateral and ipsilateral saccadic eye movements in opposite ways. Such reversed effects on contralateral and ipsilateral eye movements might be mediated by uncrossed and crossed projections from the substantia nigra pars reticulata, which receives inputs from the caudate nucleus, to the superior colliculi of both hemispheres (Beckstead et al., 1981; Jiang et al., 2003) . Taken together, the excitatory dopamine signal evoked by the stop signal would suppress caudate neurons in the indirect pathway. Suppression of the indirect pathway exerts a disinhibitory effect on contralateral saccadic eye movements, whereas the effect on ipsilateral ones turns to be inhibitory. Consequently, the excitatory dopamine signal transmitted to the indirect pathway could contribute to canceling ipsilateral saccadic eye movements.
It remains unclear, on the other hand, why blockade of dopamine D2 signaling (and D1 signaling as well) influenced the performance of canceling only ipsilateral saccadic eye movements. According to the above consideration, the pharmacological blockade should improve the performance of canceling contralateral saccadic eye movements. Consistent with our findings, a previous study in monkeys also reported that D1 and D2 antagonist injections into the caudate nucleus affected ipsilateral saccadic eye movements, but not contralateral ones, in a saccade task named the self-timed memory-guided saccade task (Kunimatsu and Tanaka, 2016) . In this task, the monkey was required to wait for a predetermined time interval (e.g., 1,100 ± 300 ms after cue offset) before making a saccadic eye movement to a remembered cue location. Thus, the monkey needed to inhibit the eye movement during the interval. Together with the previous study, our findings suggest that the caudate nucleus may predominantly regulate ipsilateral saccadic eye movements in the context in which animals need to inhibit the eye movements. Further investigations are called for to determine the precise mechanism underlying how the nigrostriatal dopamine system regulates ipsilateral saccadic eye movements.
In summary, we have defined a neural correlate of saccadic response inhibition in the nigrostriatal dopamine system as well as the causal relationship between this system and the performance of saccadic response inhibition. The indirect pathway, rather than the direct pathway, of the basal ganglia might mediate the role of the nigrostriatal dopamine system in saccadic response inhibition. Our data indicate that disruption of nigrostriatal dopamine signaling causes impairment of response inhibition, which is observed in neurological and psychiatric disorders such as Parkinson's disease.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Two adult rhesus monkeys (Macaca mulatta; monkey M, male, 8.6 kg; monkey E, male, 10.2 kg) were used in the present study. All procedures for animal care and experimentation complied with the guidelines for the Care and Use of Laboratory Animals by the University of Tsukuba, and were approved by the University of Tsukuba Animal Experiment Committee (permission number, 12-415).
METHOD DETAILS
Behavioral task
Behavioral task events and data collection were controlled by TEMPO system (Reflective Computing). The monkeys sat in a primate chair facing a computer monitor in a sound-attenuated and electrically shield room. Eye movements were monitored using an infrared eye-tracking system (Eyelink, SR research) by sampling at 500 Hz.
The monkeys were trained to perform a saccadic countermanding task ( Figure 1A) . Each trials began with the presentation of a central fixation point on the monitor (0.5 diameter), and the monkey was required to fixate the point. After the monkey maintained the fixation for 800 ms, the fixation point disappeared, and simultaneously a saccadic target (0.5 diameter) was presented at the right or left side of the point (8 eccentricity in monkey M, 10 eccentricity in monkey E). In 70% of the trials, the monkey was required to make a saccadic eye movement to the target within 550 ms and to fixate the target for 500 ms (no-stop signal trials). In the remaining 30% of the trials, the fixation point reappeared as a ''stop signal'' with a delay (referred as the stop-signal delay) after the onset of the saccadic target (stop signal trials). The monkey was then required to cancel the planned eye movement and fixate the stop signal for 600 ms (canceled trials). The correct behavior was signaled by a tone (1 kHz), and simultaneously a liquid reward was delivered. If the monkey failed to cancel and generated the eye movement to the target in stop signal trials, the stop signal and the target remained for 600 ms, and then a beep tone (100 Hz) was given without a liquid reward (non-canceled trials). Four stop-signal delays (184 to 334 ms in monkey M and 84 to 234 ms in monkeys E) were used during single-unit recording and six stop-signal delays (167 to 334 ms in monkey M, 67 to 234 ms in monkey E) were used in pharmacological experiments. All trials were presented with a random intertrial interval that was ranging from 2000 to 3000 ms.
The monkeys were also trained to perform a visually-guided saccade task. The task procedure was the same as the saccadic countermanding task except that the stop signal never appeared.
Electrophysiology
A plastic head holder and two recording chambers were fixed to the skull under general anesthesia and sterile surgical condition. One recording chamber was placed over the frontoparietal lobes, tilted laterally by 36 , and aimed at the substantia nigra pars compacta (SNc) and ventral tegmental area (VTA). The other recording chamber was placed over the midline of the frontoparietal lobes, and aimed at the caudate nucleus. The head holder and the recording chambers were embedded in dental acrylic that covered the top of the skull and were firmly anchored to the skull by plastic screws. After implanting the head holder REAGENT and recording chambers, the monkeys underwent a magnetic resonance image (MRI) scan to determine the position of the recording electrode. Single-unit recordings were performed using tungsten electrodes with impedance of 1.2 to 2.5 MU (Frederick Haer) that were introduced into the brain through a stainless-steel guide tube by an oiled-driven micromanipulator (MO-97-S, Narishige). The recording sites were determined using a grid system, which allowed recordings at every 1 mm between penetrations. For finer mapping of neurons, we also used a complementary grid which allowed electrode penetrations between the holes of the original grid.
Single-unit potentials were amplified and band-pass filtered (100Hz to 8 kHz) using a multichannel processor (MCP Plus 8, Alpha Omega) and isolated online using a voltage-time window discrimination system (ASD, Alpha omega). The time of occurrence of each action potential was stored with 1-ms resolution.
Drug injection
After all single-unit recording sessions, we injected haloperidol (5 mg/ml) and SCH23390 (10 mg/ml) that mainly prevents D2 and D1 receptor signaling, respectively, into the caudate nucleus of the two monkeys unilaterally. The injection sites were determined based on the region where we found task-related neurons in single-unit recording during the saccadic countermanding task (see Figure S5 for injection sites). The drug solutions were pressure-injected, 0.2 ml every 30 s for 10 times (2 ml in total), using a 10 ml microsyringe with a 30 gage needle (Hamilton). These doses were chosen based on previous studies in monkeys (Sawaguchi and Goldman-Rakic, 1994; Watanabe and Kimura, 1998) . We also injected the same amount of saline as a control.
For each injection experiment, the monkeys performed 600 or 700 trials of the saccadic countermanding task or 400 trials of the visually-guided saccade task before injection as a pre-injection control. We then injected haloperidol, SCH23390 or saline. Ten minutes after the injection, the monkeys started performing post-injection trials, 600 or 700 trials of the saccadic countermanding task or 400 trials of the visually-guided saccade task.
Histology
After all single-unit recording and injection experiments in monkey M, we selected representative locations of electrode penetration into the SNc and caudate nucleus, and made electrolytic microlesions (12 mA and 30 s). Then monkey M was deeply anaesthetized with pentobarbital sodium and perfused with 10% formaldehyde. The brain was blocked and equilibrated with 30% sucrose. Frozen sections were cut every 50 mm in the coronal plane, and then stained with cresyl violet.
QUANTIFICATION AND STATISTICAL ANALYSIS
To evaluate the effect of the stop-signal delay on the performance of canceling saccadic eye movements, the probability of trials in which the monkey failed to cancel an eye movement (non-canceled trials) was fit by the following logistic function
where P indicates the probability of non-canceled trials, k indicates the slope and x 0 indicates the x-value of the midpoint of the logistic curve. The SSRT, the duration that the STOP process needs to finish, was estimated based on a mathematical model that assumes a race between the GO and the STOP processes ( Figure 1C ) (Logan and Cowan, 1984) . For the estimation, the distribution of the durations of the GO process (i.e., the RTs of saccadic eye movements in no-stop signal trials) was integrated from saccadic target onset until the integral equals the proportion of non-canceled trials ( Figure 1C ). The saccadic RT at the end of the integral is the longest RT at which the GO process can finish before the STOP process. Thus, the time between the onset of the stop signal and this saccadic RT is the SSRT. We estimated the SSRTs at each stop-signal delay and averaged them for each behavioral data obtained in all single-unit recording sessions. The averaged value was assigned as the SSRT of each recording session.
To calculate spike density functions (SDFs), each spike was replaced by a combination of growth and decay exponential functions that resembles a postsynaptic potential given by the following equation where rate as a function of time, R(t), varies according to t g (the time constant for the growth phase) and t d (the time constant for the decay phase). The same equation was used by Hanes et al. (1998) . t g andt d were set to 1 and 20 ms, respectively, according to physiological data from excitatory synapses (Mason et al., 1991; Sayer et al., 1990) .
To determine whether recorded neurons are involved in canceling planned saccadic eye movements, we compared their activity in trials in which a saccadic eye movement was canceled (canceled trials) versus trials in which the eye movement was properly executed (no-stop signal trials). According to the race model, a planned saccadic eye movement is canceled in canceled trials if the STOP process finishes before the GO process. Therefore, to properly compare the activity in no-stop signal trials with that in canceled trials, we need to use only the no-stop signal trials in which the initiation of the eye movement was slow enough that the eye movement would have been canceled if the stop signal had been presented. These trials are referred as ''latencymatched no-stop signal trials'' (Hanes et al., 1998) , and the latencies of saccadic eye movements in these trials are longer than the stop-signal delay plus the SSRT. The comparison between canceled trials and latency-matched no-stop signal trials allowed us to detect a neuronal modulation related to the STOP process and counteract a neuronal modulation related to the GO process, because the GO-related neuronal modulation is presumed to be equivalent in the canceled and latency-matched no-stop signal trials.
We also compared the activity in trials in which the monkey failed to cancel a saccadic eye movement (non-canceled trials) versus trials in which the eye movement was properly executed (no-stop signal trials). According to the race model, a planned saccadic eye movement is executed in non-canceled trials if the GO process finishes before the STOP process. Therefore, to properly compare the activity in no-stop signal trials with that in non-canceled trials, we used only the no-stop signal trials in which the initiation of the eye movement was fast enough that the eye movement would have been executed even if the stop signal had been presented. These trials are also referred as ''latency-matched no-stop signal trials,'' and the latencies of saccadic eye movements in these trials are shorter than the stop-signal delay plus the SSRT.
For the above two comparisons (i.e., canceled versus latency-matched no-stop signal trials and non-canceled versus latencymatched no-stop signal trials), we calculated the neuronal activity aligned at stop signal onset not only in canceled and non-canceled trials but also in latency-matched no-stop signal trials in which the stop signal was not presented. To obtain the stop-signal aligned activity in the latency-matched no-stop signal trials, we applied a permutation procedure that has been used in previous studies (Mayse et al., 2015) . For each neuron, we first randomly sampled trials from the latency-matched no-stop signal trials to form a new data-set that had the same number of trials as the canceled trials. We then assigned the same stop-signal delays used in the canceled trials to the randomly-sampled latency-matched no-stop signal trials. We calculated the stop-signal aligned activity of the randomly-sampled latency-matched no-stop signal trials using the assigned stop-signal delays. This procedure allowed us to obtain the neuronal activity aligned at the timing when the stop signal would have been presented in the latency-matched no-stop signal trials.
To visualize the time course of neuronal modulation evoked by the stop signal for each neuron, we calculated receiver operating characteristic (ROC) value for discriminating the discharge rate in canceled versus latency-matched no-stop signal trials using a 50-ms test window sliding with a 10-ms step. We also calculated ROC value for discriminating the discharge rate in canceled versus non-canceled trials using the same procedure.
To analyze neuronal modulation elicited by the stop signal in dopamine neurons, we calculated the discharge rate of each dopamine neuron during 80 to 190 ms after stop signal onset and compared the discharge rate in canceled versus latency-matched no-stop signal trials. In caudate neurons, we calculated the discharge rate during 100 to 300 ms after stop signal onset. These time windows were chosen such that they included a major part of the neuronal modulation in canceled versus latency-matched no-stop signal trials.
We classified caudate neurons into ''increase'' and ''decrease'' types based on their response to the stop signal. We calculated the discharge rate of each caudate neuron using a 120-ms sliding window shifting from stop signal onset in a 1-ms step. If a caudate neuron showed a significant increase or decrease in the discharge rate in canceled trials compared with latency-matched no-stop signal trials during the first and at least 19 of the 20 consecutive windows, it was classified as increase or decrease type, respectively (p < 0.05, Wilcoxon rank-sum test). To filter out caudate neurons showing a significant but small modulation from the classification, we removed neurons of which the discharge rate was smaller than 2 spikes/s during the time windows in canceled and latencymatched no-stop signal trials.
To conduct population analyses, we combined the activity of each neuron in the ipsilateral and contralateral conditions if the neuron exhibited a significant modulation (i.e., increase or decrease) in the discharge rate in canceled trials versus latency-matched no-stop signal trials in both conditions (p < 0.05, Wilcoxon rank-sum test). If the neuron exhibited a significant modulation only in either of the conditions, we used the activity in that condition.
To determine whether neuronal modulation elicited by the stop signal started earlier than the SSRT, we calculated the latency of the neuronal modulation aligned at the SSRT. We defined the latency as the time when the difference in spike density function between canceled and latency-matched no-stop signal trials exceeded by 2 SD of the difference during the 250-ms time window before target onset. We used the averaged spike density function across neurons to determine the latency at the population level ( Figures 3B and  6B) , and used the spike density function of each neuron to determine the latency at the single neuron level ( Figures S4A-S4C) .
To examine the correlation between the stop-signal delay and the neuronal modulation evoked by the stop signal, we removed the data obtained using the longest stop-signal delay because the monkey failed to cancel an eye movement in most of the trials and consequently we were unable to collect enough data for statistically valid analysis.
To evaluate the effect of the D1 and D2 antagonists on the performance of canceling saccadic eye movements, we calculated the stop-signal delay at which the monkey failed in 50% of trials by fitting the performance with the logistic function, and compared the stop-signal delay in the pre-versus post-injection conditions for each injection site (see DZ in Figure 7A ). We also compared the SSRT and the RT of saccadic eye movements in the two conditions. To test a statistic significance of the effects of drug injection on the stop-signal delay incurring 50% failed trials (i.e., non-canceled trials) and the SSRT for each injection site, we applied a bootstrap procedure. For each injection site, trials were randomly resampled with replacements to form a new bootstrap data-set which had the same number of trials as the original data-set. Using the new data-set, we compared the stop-signal delay incurring 50% failed trials and the SSRT in the pre-versus post-injection conditions. Such random resampling and comparison were repeated 1,000 times. If the stop-signal delay and SSRT were larger in the pre-injection condition than in the post-injection condition or vice versa in more than 975 repetitions, the changes in these behavioral indices in the two conditions were regarded as significant.
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